Stem Cell Research (Aug 2024)

Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A)

  • Alessia Casamassa,
  • Giovannina Rotundo,
  • Chiara Ceresoni,
  • Elisa Maria Turco,
  • Isabella Torrente,
  • Ornella Candido,
  • Francesco Nicita,
  • Davide Tonduti,
  • Enrico Bertini,
  • Massimo Marano,
  • Daniela Ferrari,
  • Cristina Cereda,
  • Maria Pennuto,
  • Angelo Luigi Vescovi,
  • Stephana Carelli,
  • Jessica Rosati

Journal volume & issue
Vol. 78
p. 103468

Abstract

Read online

Hypomyelinating leukodystrophies (HLD) are a group of heterogeneous genetic disorders characterized by a deficit in myelin deposition during brain development. Specifically, 4H-Leukodystrophy is a recessive disease due to biallelic mutations in the POLR3A gene, which encodes one of the subunits forming the catalytic core of RNA polymerase III (PolIII). The disease also presents non-neurological signs such as hypodontia and hypogonadotropic hypogonadism. Here, we report the generation of a human induced pluripotent stem cell (hiPSC) line from fibroblasts of the first identified carrier of the biallelic POLR3A variants c.1802 T > A and c.4072G > A.